Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara L Weber

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
A multicenter study of cancer incidence in CHEK2 1100delC mutation carriersDeborah Thompson, Sheila Seal, Mieke Schutte, et al.
Cancer Research|December 4, 2002
BRAF and RAS mutations in human lung cancer and melanomaMarcia S Brose, Patricia Volpe, Michael Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSining Chen, Edwin S Iversen, Tara Friebel, et al.
Cancer Research|December 17, 2008
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancerNuo Yang, Sippy Kaur, Stefano Volinia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancerLori J Pierce, Albert M Levin, Timothy R Rebbeck, et al.
Annals of Internal Medicine|October 3, 2007
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani, Sining Chen, Edwin S Iversen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2008
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancerLin Zhang, Stefano Volinia, Tomas Bonome, et al.
Nature Genetics|October 9, 2007
Network modeling links breast cancer susceptibility and centrosome dysfunctionMiguel Angel Pujana, Jing-Dong J Han, Lea M Starita, et al.
Nature|November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
A multicenter study of cancer incidence in CHEK2 1100delC mutation carriersDeborah Thompson, Sheila Seal, Mieke Schutte, et al.
Cancer Research|December 4, 2002
BRAF and RAS mutations in human lung cancer and melanomaMarcia S Brose, Patricia Volpe, Michael Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSining Chen, Edwin S Iversen, Tara Friebel, et al.
Cancer Research|December 17, 2008
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancerNuo Yang, Sippy Kaur, Stefano Volinia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancerLori J Pierce, Albert M Levin, Timothy R Rebbeck, et al.
Annals of Internal Medicine|October 3, 2007
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani, Sining Chen, Edwin S Iversen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2008
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancerLin Zhang, Stefano Volinia, Tomas Bonome, et al.
Nature Genetics|October 9, 2007
Network modeling links breast cancer susceptibility and centrosome dysfunctionMiguel Angel Pujana, Jing-Dong J Han, Lea M Starita, et al.
Nature|November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Pageof 9